Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C517943 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA | increases expression | 20211987
|
C517943 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA protein | increases expression | 20211987
|
C517943 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone |
GPER protein promotes the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA] | increases expression|increases reaction | 20211987
|
C517943 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone |
PD 98059 inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C517943 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone |
Pertussis Toxin inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C035476 |
2,2',4,4'-tetrahydroxybenzophenone |
2,2',4,4'-tetrahydroxybenzophenone results in decreased expression of ESRRA mRNA | decreases expression | 15458797
|
C035476 |
2,2',4,4'-tetrahydroxybenzophenone |
2,2',4,4'-tetrahydroxybenzophenone results in increased expression of ESRRA mRNA | increases expression | 15458797
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ESRRA mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ESRRA mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to and results in decreased activity of [ESRRG protein binds to ESRRA protein] | affects binding|decreases activity | 14751226
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen binds to ESRRA protein mutant form | affects binding | 11447273
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ESRRA mRNA | affects expression | 17562736
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C004541 |
biochanin A |
biochanin A binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 14638870
|
C004541 |
biochanin A |
biochanin A binds to ESRRA protein mutant form | affects binding | 14638870
|
C004541 |
biochanin A |
biochanin A promotes the reaction [ESRRA protein binds to PNRC1 protein] | affects binding|increases reaction | 14638870
|
C004541 |
biochanin A |
biochanin A binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 16515477
|
D002330 |
Carmustine |
Carmustine results in increased expression of ESRRA mRNA | increases expression | 15980968
|
D002706 |
Chlordan |
Chlordan binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 11850205 15955695
|
D002706 |
Chlordan |
Chlordan results in decreased activity of ESRRA protein | decreases activity | 10493499
|
D002706 |
Chlordan |
Chlordan binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 16515477
|
D002976 |
Clenbuterol |
Clenbuterol results in increased expression of ESRRA mRNA | increases expression | 17446185
|
C004742 |
daidzein |
daidzein binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 14638870
|
C004742 |
daidzein |
daidzein binds to and results in increased activity of ESRRA protein mutant form | affects binding|increases activity | 14638870
|
C004742 |
daidzein |
daidzein promotes the reaction [ESRRA protein binds to PNRC1 protein] | affects binding|increases reaction | 14638870
|
C004742 |
daidzein |
daidzein binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 16515477
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 11559547
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol inhibits the reaction [ESRRA protein results in increased expression of TFF1 mRNA] | decreases reaction|increases expression | 11559547
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 16515477
|
D004958 |
Estradiol |
Estradiol results in decreased expression of ESRRA mRNA | decreases expression | 15968320
|
D004958 |
Estradiol |
Estradiol results in increased expression of ESRRA mRNA | increases expression | 15223131 20211987
|
D004958 |
Estradiol |
Estradiol results in increased expression of ESRRA protein | increases expression | 20211987
|
D004958 |
Estradiol |
fulvestrant inhibits the reaction [Estradiol results in decreased expression of ESRRA mRNA] | decreases expression|decreases reaction | 15968320
|
D004958 |
Estradiol |
GPER protein promotes the reaction [Estradiol results in increased expression of ESRRA mRNA] | increases expression|increases reaction | 20211987
|
D004958 |
Estradiol |
PD 98059 inhibits the reaction [Estradiol results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D004958 |
Estradiol |
Pertussis Toxin inhibits the reaction [Estradiol results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D004958 |
Estradiol |
Estradiol results in decreased expression of ESRRA mRNA | decreases expression | 15458797
|
D004958 |
Estradiol |
Estradiol results in increased expression of ESRRA mRNA | increases expression | 15458797 12193582
|
D004967 |
Estrogens |
Estrogens results in increased expression of ESRRA | increases expression | 15821111
|
D004967 |
Estrogens |
Estrogens results in increased expression of ESRRA mRNA | increases expression | 12960079
|
D004967 |
Estrogens |
Estrogens results in increased expression of ESRRA | increases expression | 15821111
|
D004967 |
Estrogens |
Estrogens results in increased expression of ESRRA mRNA | increases expression | 12960079
|
C043562 |
flavone |
flavone binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 14638870
|
C043562 |
flavone |
flavone binds to ESRRA protein mutant form | affects binding | 14638870
|
C070081 |
fulvestrant |
AG 1879 inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Estradiol results in decreased expression of ESRRA mRNA] | decreases expression|decreases reaction | 15968320
|
C070081 |
fulvestrant |
fulvestrant promotes the reaction [SP1 protein binds to ESRRA promoter] | affects binding|increases reaction | 20211987
|
C070081 |
fulvestrant |
fulvestrant promotes the reaction [SP3 protein binds to ESRRA promoter] | affects binding|increases reaction | 20211987
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of ESRRA mRNA | increases expression | 20211987
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of ESRRA protein | increases expression | 20211987
|
C070081 |
fulvestrant |
GPER protein promotes the reaction [fulvestrant results in increased expression of ESRRA mRNA] | increases expression|increases reaction | 20211987
|
C070081 |
fulvestrant |
PD 98059 inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C070081 |
fulvestrant |
Pertussis Toxin inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D019833 |
Genistein |
Genistein binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 15955695 14638870
|
D019833 |
Genistein |
Genistein binds to and results in increased activity of ESRRA protein mutant form | affects binding|increases activity | 14638870
|
D019833 |
Genistein |
Genistein binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 16515477
|
D007529 |
Isoflavones |
Isoflavones binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 14638870
|
D007529 |
Isoflavones |
Isoflavones binds to ESRRA protein mutant form | affects binding | 14638870
|
C082161 |
lipopolysaccharide A |
lipopolysaccharide A inhibits the reaction [ESRRA protein binds to ACADM promoter] | affects binding|decreases reaction | 16061943
|
C082161 |
lipopolysaccharide A |
lipopolysaccharide A results in decreased expression of ESRRA mRNA | decreases expression | 16061943
|
C005290 |
oxybenzone |
oxybenzone results in decreased expression of ESRRA mRNA | decreases expression | 15458797
|
D010269 |
Paraquat |
Paraquat results in decreased expression of ESRRA mRNA | decreases expression | 12595580
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Estradiol results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [Estradiol results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
C119222 |
phorbol-12-myristate |
phorbol-12-myristate promotes the reaction [ESRRA protein binds to and results in increased expression of TFF1 mRNA] | affects binding|increases expression|increases reaction | 16024613
|
D048789 |
Phytoestrogens |
Phytoestrogens binds to and results in increased activity of ESRRA protein | affects binding|increases activity | 16515477
|
D011374 |
Progesterone |
Progesterone results in increased expression of ESRRA mRNA | increases expression | 15968320
|
D013629 |
Tamoxifen |
AG 1879 inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D013629 |
Tamoxifen |
GPER protein promotes the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | increases expression|increases reaction | 20211987
|
D013629 |
Tamoxifen |
PD 98059 inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D013629 |
Tamoxifen |
Pertussis Toxin inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] | decreases reaction|increases expression | 20211987
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [SP1 protein binds to ESRRA promoter] | affects binding|increases reaction | 20211987
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [SP3 protein binds to ESRRA promoter] | affects binding|increases reaction | 20211987
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of ESRRA mRNA | increases expression | 20211987
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of ESRRA protein | increases expression | 20211987
|
D014112 |
Toxaphene |
Toxaphene binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 11356845 11850205 15955695
|
D014112 |
Toxaphene |
Toxaphene binds to and results in increased activity of ESRRA protein mutant form | affects binding|increases activity | 11356845
|
D014112 |
Toxaphene |
Toxaphene inhibits the reaction [NCOA2 protein results in increased activity of ESRRA protein] | decreases reaction|increases activity | 10493499
|
D014112 |
Toxaphene |
Toxaphene results in decreased activity of ESRRA protein | decreases activity | 10493499
|
D014112 |
Toxaphene |
Toxaphene binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 16515477
|
C012589 |
trichostatin A |
trichostatin A results in increased activity of ESRRA protein | increases activity | 11705994
|
D014425 |
Turpentine |
Turpentine results in decreased expression of ESRRA mRNA | decreases expression | 16061943
|
C488234 |
XCT790 |
XCT790 results in decreased expression of ESRRA protein | decreases expression | 19464277
|
C488234 |
XCT790 |
XCT790 binds to and affects the activity of ESRRA protein | affects activity|affects binding | 19464277
|
C488234 |
XCT790 |
XCT790 binds to and results in decreased activity of ESRRA protein | affects binding|decreases activity | 16515477
|
D015054 |
Zymosan |
Zymosan results in decreased expression of ESRRA mRNA | decreases expression | 16061943
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.22 | 14745880 |
MESH:D000210 |
Acute-Phase Reaction |
|
Turpentine |
5.85 | 16044259 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
6.76 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.76 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
6.76 | 11473722 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
8.22 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Toxaphene |
8.22 | 16132792 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.46 | 17569567 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.17 | 15469931 |
MESH:D000740 |
Anemia |
|
Zymosan |
4.28 | 18664788 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.51 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
3.92 | 15188379 15142272 15944321 16872482 17659584 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.54 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.45 | 18445737 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.01 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.94 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.11 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20961995 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
3.55 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.55 | 17289903 18497071 17261762 17018787 19861407 12948864 14630087 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
3.55 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
3.55 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Phytoestrogens |
3.55 | 17158751 17176212 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.55 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.55 | 16202921 17440819 18629630 16873071 16818667 19200415 19155303 21152245 18351453 19115204 18855134 18984771 15668708 17049068 20544844 19059307 17893378 20859285 19189210 21138602 19011961 18425577 18997820 19289846 20135344 19288272 20065188 17242785 19221464 17261762 11161223 16273361 18815881 19103187 19189212 19410462 19084267 20390343 18821012 19487384 19142967 20005174 15565566 19066611 19244106 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.14 | 16111702 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.19 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
15.89 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
15.89 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.89 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
15.89 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
15.89 | 15341023 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
15.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.89 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.33 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
15.67 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
15.67 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
15.67 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
Phytoestrogens |
15.67 | 16862667 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.39 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
5.93 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.93 | 18566989 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.23 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
2.90 | 17116718 |
MESH:D003327 |
Coronary Disease |
|
Phytoestrogens |
4.99 | 17367797 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.62 | 16670151 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.25 | 16002989 12952375 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.83 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.83 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.04 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
4.69 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.69 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.94 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.94 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.17 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
5.57 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
5.57 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.57 | 12705907 19164858 14725611 19085960 18713872 19739265 10663392 12594235 16781746 11461765 12540782 14986274 12392966 10915739 11739529 17906064 12153990 16227642 19923254 11421492 11743745 19416960 15619225 16177239 10774834 17522070 2444490 15968718 14550746 18071297 16485898 16081117 17562736 11834606 11529661 11287661 19370779 12958197 16393943 16109766 19420014 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.77 | 19426721 |
MESH:D004487 |
Edema |
|
Zymosan |
3.71 | 7907874 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.14 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.14 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.31 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
18.48 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
18.48 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Phytoestrogens |
18.48 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
31.81 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
31.81 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
31.81 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
31.81 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
31.81 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Phytoestrogens |
31.81 | 16543667 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
31.81 | 16202921 20544844 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.49 | 16134523 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.71 | 14972507 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
2.88 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
7.55 | 15751030 16534752 16513791 16611131 16002989 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
7.55 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.20 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.86 | 19069698 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.34 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.62 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
biochanin A |
15.35 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
15.35 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
15.35 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
15.35 | 18801729 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.83 | 11124998 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.39 | 19110552 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.70 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.32 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
9.32 | 14716179 17290160 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.45 | 16870215 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.12 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
daidzein |
3.55 | 17169123 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.26 | 16002989 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.08 | 15869954 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.05 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Chlordan |
14.51 | 9432128 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
14.51 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
14.51 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Phytoestrogens |
14.51 | 16731787 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.51 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.51 | 19457130 |
MESH:D007249 |
Inflammation |
|
Zymosan |
7.51 | 8014878 11289658 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.76 | 16393666 16627594 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.51 | 17553498 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.26 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.26 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
20.55 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
20.55 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
20.55 | 16762066 15003126 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.55 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
20.55 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.75 | 17184923 |
MESH:D007938 |
Leukemia |
|
Genistein |
2.86 | 17468513 18980019 |
MESH:D007945 |
Leukemia, Lymphoid |
|
Toxaphene |
5.96 | 16132792 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
4.90 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
2.85 | 18206229 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.93 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.31 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.31 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.31 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.55 | 16611625 12969438 19460945 19014921 12587719 19784758 11587558 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.96 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
12.95 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Chlordan |
12.95 | 2422723 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
12.95 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
12.95 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
XCT790 |
12.95 | 19464277 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.35 | 6135515 2876786 2876784 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
1.73 | 18625569 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.82 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.24 | 15700306 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.18 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.44 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.56 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
12.56 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
12.56 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
12.56 | 19196723 14580682 19196722 11731420 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.54 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.54 | 19453300 |
MESH:D008545 |
Melanoma |
|
Carmustine |
4.95 | 12393984 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.95 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
4.95 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.86 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.25 | 19513568 |
MESH:D008659 |
Metabolic Diseases |
therapeutic |
|
| 16515477 |
MESH:D008881 |
Migraine Disorders |
|
Phytoestrogens |
4.76 | 12224599 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
3.64 | 18172295 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.91 | 12130978 10479408 15241586 15259001 18160304 15213630 17724436 12879239 15834315 10890648 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.72 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.69 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.69 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.26 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.26 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.41 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.41 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
5.35 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Toxaphene |
5.35 | 8820588 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Phytoestrogens |
10.25 | 16912569 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
10.25 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.41 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.47 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
14.70 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.70 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
14.70 | 16427766 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.61 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.95 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.95 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.92 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
6.92 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.79 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.44 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.44 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.44 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
10.44 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.14 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
3.17 | 19294695 |
MESH:D010195 |
Pancreatitis |
|
Phytoestrogens |
4.94 | 17269527 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.69 | 15824117 12911755 11181820 11445065 16140633 15451049 11124998 16510128 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.11 | 16190885 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.57 | 17371808 18977430 18557954 15979727 17826846 18760300 15259001 14761945 19641140 11985352 19088179 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.84 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.35 | 15687265 16977796 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.13 | 12504350 |
MESH:D011248 |
Pregnancy Complications |
|
Toxaphene |
5.54 | 2087686 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
3.79 | 17184923 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
4.93 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.59 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
biochanin A |
2.38 | 12111696 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.38 | 17136230 15046698 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.38 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.38 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.38 | 17374662 17571952 16365062 17219775 |
MESH:D011471 |
Prostatic Neoplasms |
|
Phytoestrogens |
2.38 | 16921512 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.38 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.38 | 19789329 18798265 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.79 | 16324872 17997886 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.61 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.74 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.63 | 16458197 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.74 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.14 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.14 | 18551238 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.38 | 11441115 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
10.74 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.74 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.79 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.79 | 19457130 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.35 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
10.83 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
10.83 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
10.83 | 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
10.83 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.90 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.90 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.68 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
3.75 | 16175088 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.84 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.76 | 15809267 16690809 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.07 | 11006244 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.12 | 16002989 16513791 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.48 | 11172683 |